BlueCrest Capital Management’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

BlueCrest Capital Management’s Portfolio PHGE.WS Stock Details PHGE.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,060,500	Closed	-$1.61K	–	301
2022 Q4	$1.61K	Buy	8,060,500 +7,979,895	+9,900%	+$184K	﹤0.01%	156
2022 Q3	$3K	Hold	80,605	–	–	﹤0.01%	183
2022 Q2	$3K	Hold	80,605	–	–	﹤0.01%	190
2022 Q1	$11K	Hold	80,605	–	–	﹤0.01%	270
2021 Q4	$9K	Hold	80,605	–	–	﹤0.01%	300
2021 Q3	$27K	Hold	80,605	–	–	﹤0.01%	365
2021 Q2	$48K	Hold	80,605	–	–	﹤0.01%	498
2021 Q1	$52K	Hold	80,605	–	–	﹤0.01%	626
2020 Q4	$64K	Hold	80,605	–	–	﹤0.01%	356
2020 Q3	$57K	Hold	80,605	–	–	﹤0.01%	290
2020 Q2	$39K	Hold	80,605	–	–	﹤0.01%	244
2020 Q1	$48K	Hold	80,605	–	–	﹤0.01%	195
2019 Q4	$38K	Buy	+80,605	New	+$50.2K	﹤0.01%	368

Other funds holding PHGE.WS

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

BlueCrest Capital Management's PHGE.WS Position: Q1 2023 in Review

BlueCrest Capital Management sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q1 2023, closing a stake of 8,060,500 shares — an estimated $1.61K sold.

BlueCrest Capital Management first reported a position in PHGE.WS in Q4 2019 and held it in 13 quarters. The position peaked at $64K in Q4 2020. 8 funds tracked by Wall St. Rank hold PHGE.WS as of Q1 2023.

BlueCrest Capital Management reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q1 2023 after selling out during the quarter.
BlueCrest Capital Management sold 8,060,500 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q1 2023, an estimated $1.61K.
BlueCrest Capital Management first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q4 2019 and held it in 13 quarters.
BlueCrest Capital Management's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $64K in Q4 2020.
8 funds tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q1 2023.

Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.